You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.

Gm and Happy Friday!

Bitcoin dived below $80,000 in the early morning hours on Friday but has at least recovered somewhat to over $83,000. What’s driving this crash?

Michael Saylor is willing to go to great lengths to keep his Bitcoin. Even selling a kidney may be on the table.

Plus, every week, our Whisper Index uncovers five overlooked stocks with big breakout potential. Get the latest picks today before they gain traction.

Click here to access this week’s report now.

TOP STORY

Bitcoin Plummets Below $80,000, Ethereum, XRP, Dogecoin Get Hammered As Crypto Crash Continues

A rough morning for Bitcoin, with the crypto king plunging below $79,000.

At the time of this newsletter, Bitcoin is comfortably back above $83,000 again but far from being out of the woods.

The crypto crash has deepened this week off the back of several catalysts.

What’s driving the market?

Read the full scoop here.

SPECIAL OFFER

5 Stocks Wall Street Hasn’t Noticed—Yet

Every week, our Whisper Index uncovers five overlooked stocks with big breakout potential. Get the latest picks today before they gain traction.

Click here to access this week’s report now.

QUICK N DIRTY

Bitcoin might be not doing so well right now, but it’s still going to hit $500,000 before Donald Trump leaves office, according to Standard Chartered.

XRP is down over 20% in 7 days. How much lower can it go?

Bitcoin down 24% from its highs? Just a ‘technical correction,’ according to analysts Benzinga spoke to at ETH Denver.

FINTECH FOCUS

Michael Saylor Says 'Sell A Kidney, But Keep The Bitcoin', But MSTR Is Down 28% Since He Appeared On The Cover Of Forbes

Would you sell a kidney to keep your Bitcoin?

Michael Saylor jokes it would be worth it. The Strategy executive chairman motivated his followers on X to do anything to keep their Bitcoin.

But did you know that since he appeared on the cover of Forbes, MSTR is down 28%?

Read the full scoop here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this daily newsletter delivers top stories, fast movers and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.